Eagle Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $44k | 8.4k | 5.23 |
| 2023-09-30 | $282k | 18k | 15.78 |
| 2023-06-30 | $725k | 37k | 19.44 |
| 2023-03-31 | $304k | 11k | 28.38 |
| 2022-12-31 | $1.3M | 46k | 29.24 |
| 2022-09-30 | $198k | 9.9k | 20.00 |
| 2022-06-30 | $374k | 8.5k | 43.86 |
| 2022-03-31 | $1.3M | 27k | 48.78 |
| 2021-12-31 | $2.0M | 34k | 60.00 |
| 2021-09-30 | $1.4M | 23k | 60.00 |
| 2021-06-30 | $324k | 8.1k | 40.00 |
| 2021-03-31 | $888k | 21k | 41.74 |
| 2020-12-31 | $2.0k | 50 | 40.00 |
| 2020-09-30 | $2.0k | 50 | 40.00 |
| 2020-06-30 | $2.0k | 50 | 40.00 |
| 2020-03-31 | $160k | 3.5k | 45.91 |
| 2019-12-31 | $349k | 5.7k | 61.45 |
| 2019-09-30 | $1.5M | 26k | 55.87 |
| 2019-06-30 | $2.3M | 42k | 55.67 |
| 2019-03-31 | $176k | 3.3k | 53.10 |
| 2018-12-31 | $3.2M | 81k | 38.83 |
| 2018-09-30 | $822k | 12k | 69.47 |
| 2018-06-30 | $36k | 479 | 75.16 |
| 2018-03-31 | $2.5M | 48k | 52.79 |
| 2017-12-31 | $550k | 10k | 52.94 |
| 2017-09-30 | $1.6M | 28k | 59.65 |
| 2017-06-30 | $1.1M | 14k | 78.86 |
| 2017-03-31 | $111k | 1.3k | 83.16 |
| 2016-12-31 | $1.6M | 20k | 79.33 |
| 2016-09-30 | $876k | 13k | 70.00 |
| 2016-06-30 | $713k | 18k | 40.00 |
| 2016-03-31 | $364k | 9.1k | 40.00 |
| 2015-12-31 | $2.8M | 31k | 88.66 |
| 2015-09-30 | $513k | 6.9k | 74.01 |